For better adhesion, superglue was added to the transmitter adhesive patch prior ... which may have contributed to the differences in accuracy and lifespan between the two studies. Furthermore, Byrd ...

Every few minutes, the transmitter ... of life for diabetic patients by enhancing comfort, reducing invasive procedures, and enabling better management of blood glucose levels. Recently, the US Food ...

we see Drury doing a routine on a trampoline while wearing one of Dexcom’s continuous glucose monitors (CGMs). In a voice-over, Jonas says, “if it feels like a diagnosis has turned your life ...

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...

In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed ...

Looking at the results in more detailed, we can see that Dexcom struggled, especially in the United States. Revenue declined 1.6% year-over-year from $713.6 million in Q3/23 to $701.9 million in ...

Amid the launch of its first over-the-counter wearable glucose tracker, Dexcom reported that its overall revenues in the U.S. declined year over year despite overall sales coming in slightly ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity maintained a Buy rating on the ...

DexCom (NASDAQ:DXCM) reported third-quarter earnings that surpassed analyst expectations, but the company's stock plummeted 16% as revenue growth slowed significantly. The continuous glucose ...

Shares of Dexcom (NASDAQ:DXCM) fell 16% in post-market trading Thursday after the company released its Q3 earnings report which showed only modest topline growth over last year’s quarter.